^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    porustobart (HBM4003)

    i
    Other names: HBM4003, HBM 4003, HBM-4003
    Associations
    News
    Trials
    Company:
    Harbour BioMed, Solstice Oncology
    Drug class:
    CTLA4 inhibitor
    Related drugs:
    Associations
    News
    Trials